The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors
Abstract
Imaging studies of serotonin transporter binding or tryptophan retention in autistic patients suggest that the brain serotonin system is decreased. However, treatment with drugs which increase serotonin (5-HT) levels, specific serotonin reuptake inhibitors (SSRIs), commonly produce a worsening of the symptoms. In this study we examined 5-HT axons that were immunoreactive to a serotonin transporter (5-HTT) antibody in a number of postmortem brains from autistic patients and controls with no known diagnosis who ranged in age from 2 to 29 years. Fine, highly branched, and thick straight fibers were found in forebrain pathways (e.g. medial forebrain bundle, stria terminalis and ansa lenticularis). Many immunoreactive varicose fine fibers were seen in target areas (e.g. globus pallidus, amygdala and temporal cortex). Morphometric analysis of the stained axons at all ages studied indicated that the number of serotonin axons was increased in both pathways and terminal regions in cortex from autism donors. Our findings provide morphological evidence to warrant caution when using serotonin enhancing drugs (e.g. SSRIs and receptor agonist) to treat autistic children. This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An increased number of 5-HT axons and terminals were reported in a variety of brain regions via immunocytochemical labeling of 5-HT transporter in post-mortem autism subjects aged 2–29 years old bringing into question the wide use of SSRIs as therapeutic agents [187].”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [187]
Citations
Cites
Autism as a strongly genetic disorder: evidence from a British twin study
Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., & Rutter, M. (1995) · Psychological Medicine · doi:10.1017/s0033291700028099 · Cited by 2,461
Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Shapiro, D. A., Renock, S. M., Arrington, E. G., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 982
Risk Factors for Autism: Perinatal Factors, Parental Psychiatric History, and Socioeconomic Status
Larsson, H. J., Eaton, W. W., Madsen, K. M., Vestergaard, M., Olesen, A. V., Agerbo, E., Schendel, D., Thorsen, P., & Mortensen, P. B. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi123 · Cited by 727
Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
Owen, R., Sikich, L., Marcus, R. N., Corey-Lisle, P., Manos, G., McQuade, R. D., Carson, W. H., & Findling, R. L. (2009) · Pediatrics · doi:10.1542/peds.2008-3782 · Cited by 613
Binding of antipsychotic drugs to human brain receptors
Richelson, E., & Souder, T. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00911-5 · Cited by 608
Perinatal Factors and the Development of Autism
Glasson, E. J., Bower, C. I., Petterson, B., de Klerk, N. H., Chaney, G., & Hallmayer, J. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.618 · Cited by 542
King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., Donnelly, C. L., Anagnostou, E., Dukes, K., Sullivan, L., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.30 · Cited by 482
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
Williams, K., Brignell, A., Randall, M., Silove, N., & Hazell, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004677.pub3 · Cited by 415
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–106 of 106
Animal models of the human mind: Is there anything like being autistic?
Pascual, J. M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.10.008
Serotonin : from mouse models to human disorders
Jensen, A. L. (2014) · ScholarSpace (University of Hawaii at Manoa)
Martínez‐Cerdeño, V. (2016) · CRC Press eBooks · doi:10.1201/9781315371375-5
Fabio, M. C., Mujica, V., Fogliatti, E., Aguilar, M. V., Degano, A. L., & Pautassi, R. M. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5157873
Griffioen, G., Hildalgo, N., Sorjonen, K., Andersson, M., Tangen, Ä., Chin, L., Lundberg, J., Halldin, C., Bölte, S., & Borg, J. (2025) · Research Square · doi:10.21203/rs.3.rs-7525895/v1
BindingDB Entry 50002441: Structure-Activity Relationships and Therapeutic Potentials of 5-HT
BindingDB (2020) · UC San Diego · doi:10.7270/q2v98bpm
Metadata
- Authors
- Azmitia, E. C., Singh, J. S., & Whitaker-Azmitia, P. M.
- Affiliations
- New York University (US)
- Corresponding author
- Azmitia, Efrain C.
- ORCID
- Azmitia, Efrain C.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 60
- Issue
- 7-8
- Pages
- 1347-1354
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W1999133104
- Cited by
- 107
- References
- 53
- Citations by year
- 2025: 6 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 5 · 2020: 10 · 2019: 6 · 2018: 8 · 2017: 6 · 2016: 8 · 2015: 8 · 2014: 11 · 2013: 13 · 2012: 9
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- autism spectrum disorder, serotonin, serotonin transporter, serotonergic system, serotonin reuptake inhibitors, SSRI adverse effects, autism pharmacotherapy, postmortem brain, axon morphology, medial forebrain bundle, stria terminalis, ansa lenticularis, globus pallidus, amygdala, temporal cortex
- MeSH terms
- Adolescent, Adult, Autistic Disorder, Autopsy, Axons, Brain, Child, Child, Preschool, Female, Globus Pallidus, Humans, Male, Medial Forebrain Bundle, Nerve Fibers, Serotonin, Temporal Lobe, Prosencephalon, Subthalamus, Serotonin Plasma Membrane Transport Proteins, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review